Cargando…

Risk factors associated with 90-day recurrent stroke in patients on dual antiplatelet therapy for minor stroke or high-risk TIA: a subgroup analysis of the CHANCE trial

OBJECTIVE: Many patients receiving dual antiplatelet therapy still had recurrent strokes. We aimed to identify factors associated with recurrent stroke at 90 days in patients receiving dual antiplatelet therapy in Clopidogrel in High-risk patients with Acute Non-disabling Cerebrovascular Events tria...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wangqin, Runqi, Wang, Xianwei, Wang, Yilong, Xian, Ying, Zhao, Xingquan, Liu, Liping, Li, Hao, Meng, Xia, Wang, Yongjun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5829906/ https://www.ncbi.nlm.nih.gov/pubmed/29507777 http://dx.doi.org/10.1136/svn-2017-000088

Ejemplares similares

Association of elevated hs-CRP and multiple infarctions with outcomes of minor stroke or TIA: subgroup analysis of CHANCE randomised clinical trial
por: Wang, Guangyao, et al.
Publicado: (2020)

Effect of dual antiplatelet on recurrent stroke in minor stroke or TIA depends on bodyweight
por: Ma, Yan, et al.
Publicado: (2018)

LDL-C levels, lipid-lowering treatment and recurrent stroke in minor ischaemic stroke or TIA
por: Pan, Yuesong, et al.
Publicado: (2022)

Different levels of blood pressure, different benefit from dual antiplatelet therapy in minor stroke or TIA patients
por: Xu, Jie, et al.
Publicado: (2017)

Platelet Count Predicts Adverse Clinical Outcomes After Ischemic Stroke or TIA: Subgroup Analysis of CNSR II
por: Yang, Ming, et al.
Publicado: (2019)

Dual antiplatelet therapy may increase the risk of non-intracranial haemorrhage in patients with minor strokes: a subgroup analysis of the CHANCE trial
por: Wang, David, et al.
Publicado: (2016)

Ticagrelor Is Superior to Clopidogrel in Inhibiting Platelet Reactivity in Patients With Minor Stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

Antiplatelet effect of ticagrelor with aspirin in acute minor stroke and transient ischemic attack stratified by CYP2C19 metabolizer status: subgroup analysis of the PRINCE trial
por: Zhou, Mengyuan, et al.
Publicado: (2020)

Effect of ticagrelor versus clopidogrel on platelet reactivity measured by thrombelastography in patients with minor stroke or TIA
por: Yang, Yingying, et al.
Publicado: (2020)

Factors for short-term outcomes in patients with a minor stroke: results from China National Stroke Registry
por: Wu, Lingyun, et al.
Publicado: (2015)

Does all single infarction have lower risk of stroke recurrence than multiple infarctions in minor stroke?
por: Wang, Guangyao, et al.
Publicado: (2019)

Patterns and predictors of antihypertensive medication used 1 year after ischemic stroke or TIA in urban China
por: Xu, Jie, et al.
Publicado: (2013)

European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
por: Dawson, Jesse, et al.
Publicado: (2021)

European Stroke Organisation expedited recommendation for the use of short-term dual antiplatelet therapy early after minor stroke and high-risk TIA
por: Dawson, Jesse, et al.
Publicado: (2021)

Interleukin-6 and YKL-40 predicted recurrent stroke after ischemic stroke or TIA: analysis of 6 inflammation biomarkers in a prospective cohort study
por: Li, Jiejie, et al.
Publicado: (2022)

Acute dual antiplatelet therapy for minor ischaemic stroke or transient ischaemic attack
por: Wang, Yongjun, et al.
Publicado: (2019)

Intravenous thrombolysis versus antiplatelet therapy in minor stroke patients with large vessel occlusion
por: Duan, Chunmiao, et al.
Publicado: (2023)

Using the PEAR1 Polymorphisms Rs12041331 and Rs2768759 as Potential Predictive Markers of 90-Day Bleeding Events in the Context of Minor Strokes and Transient Ischemic Attack
por: Xu, Yanjie, et al.
Publicado: (2023)

Microalbuminuria could improve risk stratification in patients with TIA and minor stroke
por: Elyas, Salim, et al.
Publicado: (2016)

Dual versus mono antiplatelet therapy for acute non-cardioembolic ischaemic stroke or transient ischaemic attack: a systematic review and meta-analysis
por: Yang, Yingying, et al.
Publicado: (2018)

Dual antiplatelet therapy with ticagrelor may increase the risk of all bleeding events in patients with minor strokes or high risk TIAs: a meta-analysis
por: Chen, Xi, et al.
Publicado: (2022)

Predictive Value of the ABCD3-I for Short- and Long-Term Stroke after TIA with or without sICAS
por: Xie, Xuewei, et al.
Publicado: (2022)

Rationale and design of a randomised double-blind 2×2 factorial trial comparing the effect of a 3-month intensive statin and antiplatelet therapy for patients with acute mild ischaemic stroke or high-risk TIA with intracranial or extracranial atherosclerosis (INSPIRES)
por: Gao, Ying, et al.
Publicado: (2023)

Metabolic Syndrome and Stroke Recurrence in Chinese Ischemic Stroke Patients – The ACROSS-China Study
por: Mi, Donghua, et al.
Publicado: (2012)

Comparison of outcome of patients with acute minor ischaemic stroke treated with intravenous t-PA, DAPT or aspirin
por: Wang, Peng, et al.
Publicado: (2020)

Gastrointestinal bleeding during acute ischaemic stroke hospitalisation increases the risk of stroke recurrence
por: Du, Wanliang, et al.
Publicado: (2020)

Early Identification of High-Risk TIA or Minor Stroke Using Artificial Neural Network
por: Chan, Ka Lung, et al.
Publicado: (2019)

The design, rationale, and baseline characteristics of a nationwide cohort registry in China: blood pressure and clinical outcome in TIA or ischemic stroke
por: Xu, Jie, et al.
Publicado: (2016)

Association between marriage and outcomes in patients with acute ischemic stroke
por: Liu, Qi, et al.
Publicado: (2018)

Treatment Effect of Clopidogrel Plus Aspirin Within 12 Hours of Acute Minor Stroke or Transient Ischemic Attack
por: Li, Zixiao, et al.
Publicado: (2016)

Cost‐Effectiveness of Clopidogrel‐Aspirin Versus Aspirin Alone for Acute Transient Ischemic Attack and Minor Stroke
por: Pan, Yuesong, et al.
Publicado: (2014)

Prediction Factors of Recurrent Ischemic Events in One Year after Minor Stroke
por: Zhang, Changqing, et al.
Publicado: (2015)

Risk factors for decline in Montreal Cognitive Assessment (MoCA) scores in patients with acute transient ischemic attack and minor stroke
por: Zuo, Lijun, et al.
Publicado: (2022)

Early time course of major bleeding on antiplatelet therapy after TIA or ischemic stroke
por: Hilkens, Nina A., et al.
Publicado: (2018)

Atrial fibrillation is not uncommon among patients with ischemic stroke and transient ischemic stroke in China
por: Yang, Xiaomeng, et al.
Publicado: (2017)

International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke: Analysis of the China National Stroke Registry and the American Heart Association Get With The Guidelines––Stroke Program
por: Wangqin, Runqi, et al.
Publicado: (2018)

The association of white matter hyperintensities with stroke outcomes and antiplatelet therapy in minor stroke patients
por: Xu, Yu-Yuan, et al.
Publicado: (2020)

Prognostic Value of International Normalized Ratio in Ischemic Stroke Patients without Atrial Fibrillation or Anticoagulation Therapy
por: Xie, Xuewei, et al.
Publicado: (2019)

The Association Between Heart Rate Variability and 90-Day Prognosis in Patients With Transient Ischemic Attack and Minor Stroke
por: Li, Changhong, et al.
Publicado: (2021)

MRA-detected intracranial atherosclerotic disease in patients with TIA and minor stroke
por: Dempsey, Philip J., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_uag5sgfk7fhphtijime2clp0uf